Neoceptin R 75 mg/5 ml (Syrup)
100 ml bottle: ৳ 50.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Beximco pharmaceuticals ltd |
| Also available as |
Indications
- Treatment of active duodenal ulcer
- Benign gastric ulcer
- Prevention of ulcer associated with non-steroidal anti-inflammatory agent
- Post operative stress ulcer
- Zollinger-Ellison Syndrome
- Gastroesophageal reflux disease (GERD)
- Gastro-intestinal haemorrhage treatment
- Recurrent haemorrhage treatment
- Prevention of acid aspiration risk
- Maintenance for preventing recurrences
Pharmacology
- Competitively blocks histamine at H2-receptors
- Inhibits gastric acid secretion
- Does not affect pepsin secretion or serum gastrin
Dosage & Administration
- 150 mg twice daily for duodenal and gastric ulcer
- 300 mg as a single daily dose at night for 4 to 8 weeks
- 150 mg twice daily for reflux esophagitis
- 150 mg 3 times daily for Zollinger Ellison syndrome
- 150 mg twice daily for episodic dyspepsia
- Maintenance dosage at 150 mg
- Parenteral administration options for stress ulceration and peptic ulceration
- Injectable dosage for children based on weight
- Dosage adjustments for specific medical conditions
Interaction
- Delayed absorption with propantheline bromide
- Minimally inhibits hepatic metabolism of certain drugs
- Alters absorption of pH-dependent drugs
- Reduces bioavailability with antacids
Contraindications
- Hypersensitivity to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy & Lactation
- Crosses placenta
- Caution during pregnancy
- Excreted in human breast milk
- Caution during lactation
Precautions & Warnings
- Reduced dosage for impaired renal and hepatic function
Use in Special Populations
- Elderly patients - similar ulcer healing rates observed
- No difference in adverse effects in elderly patients
Overdose Effects
- Specific action minimizes problems with overdosage
- Symptomatic and supportive therapy recommended
- Potential for removal by hemodialysis
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Slow IV injection guidelines
- Intermittent slow IV infusion recommendations
- Continuous IV infusion instructions
- Dilution guidelines for specific medical conditions
Storage Conditions
- Store in a cool and dry place
- Protect from light